There is a problem with the stock price data. Our supplier is working to solve the issue.
Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
3 months
Bryan GarnierPareto SecuritiesSEBSEB EquitiesCarnegieDanske BankDanske Bank Markets

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
Bryan Garnier340 SEKNov 13
Pareto Securities280 SEKOct 25
SEB415 SEKSep 29
SEB Equities410 SEKJun 21
Carnegie385 SEKApr 25
Danske Bank403 SEKOct -22
Danske Bank Markets448 SEKJun -21

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion